Elizabeth R. Vázquez

Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first‐line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

John D. Hainsworth, Elizabeth R. Vázquez, David R. Spigel et al. · Cancer · 2008 · 34 citations · Full text

Medicine, Immunology, Oncology +14

Brief-Duration Rituximab/Chemotherapy Followed by Maintenance Rituximab in Patients With Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

John D. Hainsworth, Ian W. Flinn, David R. Spigel et al. · Clinical Lymphoma Myeloma & Leukemia · 2010 · 32 citations

Medicine, Oncology, Pharmacotherapy +10

A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer

Denise A. Yardley, John D. Zubkus, Brooke Daniel et al. · Clinical Breast Cancer · 2010 · 20 citations

Medicine, Oncology, Pharmacology +13

A Phase II Randomized Crossover Study of Liposomal Doxorubicin Versus Weekly Docetaxel in the First-line Treatment of Women With Metastatic Breast Cancer

Denise A. Yardley, Howard A. Burris, David R. Spigel et al. · Clinical Breast Cancer · 2009 · 12 citations

Medicine, Oncology, Pharmacology +15

Phase II Study of Cetuximab, Docetaxel, and Gemcitabine in Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer

David R. Spigel, F. Anthony Greco, Dana S. Thompson et al. · Clinical Lung Cancer · 2010 · 12 citations

Medicine, Oncology, Pharmacology +12